Conventional serum biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA19‐9) are widely employed, but their diagnostic performance for early‐stage CRC is not satisfactory.2 The gene discussed is CEACAM5; the disease is colorectal carcinoma.